相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Towards a therapy for phosphomannomutase 2 deficiency, the defect in CDG-Ia patients
Hudson H. Freeze
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Functional Analysis of Three Splicing Mutations Identified in the PMM2 Gene: Toward a New Therapy for Congenital Disorder of Glycosylation type IA
Ana I. Vega et al.
HUMAN MUTATION (2009)
Functional Properties of Missense Variants of Human Tryptophan Hydroxylase 2
Jeffrey A. McKinney et al.
HUMAN MUTATION (2009)
Congenital Disorders of Glycosylation: An Update on Defects Affecting the Biosynthesis of Dolichol-Linked Oligosaccharides
Micha A. Haeuptle et al.
HUMAN MUTATION (2009)
Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability
Soren W. Gersting et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Identification of pharmacological chaperones as potential therapeutic agents to treat phenylketonuria
Angel L. Pey et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Predicted effects of missense mutations on native-state stability account for phenotypic outcome in phenylketonuria, a paradigm of misfolding diseases
Angel L. Pey et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Mono, di and tri-mannopyranosyl phosphates as mannose-1-phosphate prodrugs for potential CDG-Ia therapy
Renaud Hardre et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The X-ray crystal structures of human α-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a
Nicholas R. Silvaggi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts
EA Eklund et al.
GLYCOBIOLOGY (2005)
Pharmacological chaperones:: potential treatment for conformational diseases
V Bernier et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Therapeutic approaches to protein-misfolding diseases
FE Cohen et al.
NATURE (2003)
Phenylketonuria:: Genotype-phenotype correlations based on expression analysis of structural and functional mutations in PAH
AL Pey et al.
HUMAN MUTATION (2003)
Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia
V Westphal et al.
GENETICS IN MEDICINE (2001)
High residual activity of PMM2 in patients' fibroblasts:: Possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency)
S Grünewald et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Identification of four novel PMM2 mutations in congenital disorders of glycosylation (CDG) Ia French patients
S Vuillaumier-Barrot et al.
JOURNAL OF MEDICAL GENETICS (2000)
Congenital disorders of glycosylation
G Matthijs
TRENDS IN BIOCHEMICAL SCIENCES (2000)
分享论文
